Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

J Torre-Cisneros, JM Aguado, JJ Caston… - Transplantation …, 2016 - Elsevier
Cytomegalovirus (CMV) infection remains a major complication of solid organ
transplantation. Because of management of CMV is variable among transplant centers, in …

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and …

Y Mizukawa, K Hirahara, Y Kano, T Shiohara - Journal of the American …, 2019 - Elsevier
Background The prognosis of drug-induced hypersensitivity syndrome (DiHS)/drug reaction
with eosinophilia and systemic symptoms (DRESS) is highly unpredictable. Severe …

Going beyond serology for stratifying the risk of CMV infection in transplant recipients

D Navarro, M Fernández‐Ruiz… - Reviews in Medical …, 2019 - Wiley Online Library
Knowledge of donor and recipient (D/R) cytomegalovirus (CMV) serostatus is critical for risk
stratification of CMV infection and disease in transplant recipients, particularly in the solid …

[HTML][HTML] 肝移植术后感染相关危险因素的研究进展

赵云, 赵礼金 - 临床肝胆病杂志, 2021 - lcgdbzz.org
随着外科技术的不断发展, 肝移植术已趋于成熟, 但术后感染依然是肝移植手术失败的主要原因
之一. 研究者们通过对术后感染相关危险因素的不断探索发现, 除既往报道的危险因素外 …

Predictors of CMV infection in CMV-seropositive kidney transplant recipients: impact of pretransplant CMV-specific humoral immunity

S Kirisri, A Vongsakulyanon… - Open Forum …, 2021 - academic.oup.com
Background Although cytomegalovirus (CMV)-seropositive solid organ transplant recipients
have a relatively lower risk of CMV infection than CMV-seronegative recipients who receive …

[HTML][HTML] Impact of anti-CMV IgG titers and CD34 count prior to hematopoietic stem cell transplantation from alternative donors on CMV reactivation

LJ Arcuri, M Schirmer, M Colares, S Maradei… - Biology of Blood and …, 2020 - Elsevier
Cytomegalovirus (CMV) reactivation remains one of the main infectious complications
following hematopoietic stem cell transplantation (HSCT). In this study, we explored the role …

Prevention and management of CMV infections after liver transplantation: current practice in German transplant centers

C Engelmann, M Sterneck, KH Weiss… - Journal of Clinical …, 2020 - mdpi.com
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …

Prediction of cytomegalovirus reactivation by recipient cytomegalovirus-IgG titer before allogeneic hematopoietic stem cell transplantation

S Kawamura, H Nakasone, J Takeshita… - … and Cellular Therapy, 2021 - Elsevier
Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …

Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis

M Morishita, KE Sada, Y Matsumoto, K Hayashi… - Plos one, 2019 - journals.plos.org
Aims Cytomegalovirus (CMV) infection under immunosuppression sometimes causes death.
This study aimed to elucidate risk factors for CMV infection in patients with antineutrophil …

A prospective study of cytomegalovirus-specific cell-mediated immune monitoring and cytomegalovirus infection in patients with active systemic lupus erythematosus …

J Bruminhent, S Autto, P Rotjanapan… - Open Forum …, 2021 - academic.oup.com
Background The effects of cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) on
CMV infection in patients with autoimmune diseases receiving immunosuppressants have …